Literature DB >> 7514587

Human androgen receptor binding to the androgen response element of prostate specific antigen.

M C Luke1, D S Coffey.   

Abstract

This study examined the in vitro interaction of the human androgen receptor with a putative androgen response element (ARE) in the promoter region of the prostate specific antigen (PSA) gene. To characterize the androgen receptor's interactions with its DNA response elements we expressed the full length human androgen receptor protein in a baculovirus expression system. The receptor was shown to be 110 kDa by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and was purified using ion-exchange column chromatography. Binding of the synthetic androgen R1881 to the unpurified recombinant receptor exhibited a kd of 7.6 nM by Scatchard analysis. In DNA gel electromobility shift assays the promoter region from PSA (a 313-bp fragment) was bound by the unpurified recombinant androgen receptor in a sequence-specific manner. An ARE-containing sequence from the promoter region of the PSA gene was synthesized as a 30-bp oligonucleotide and was shown to bind specifically to the human androgen receptor in gel electromobility shift assays by DNA competition and by antibody supershifts of the receptor-ARE complex. The specific binding of the insect cell expressed androgen receptor to its ARE was shown to occur even in the absence of androgen. Androgen receptors purified by ion-exchange chromatography were unable to bind to ARE, suggesting the presence of other factors required for DNA binding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514587

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  17 in total

1.  Elevated serum prostate-specific antigen and pancreatic carcinoma.

Authors:  L R Ranganath; G A Lewis; B T Nobbs; P F Goddard; D C Rangedera
Journal:  Postgrad Med J       Date:  1996-06       Impact factor: 2.401

2.  Prostate-specific antigen kallikrein and the heart.

Authors:  Salvatore Patanè
Journal:  World J Cardiol       Date:  2009-12-31

3.  Serum prostate-specific antigen concentration is increased in acromegalic women.

Authors:  L Manetti; I Lupi; M Genovesi; L Morselli; L Grasso; C Nencetti; M Gasperi; F Bogazzi; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

4.  Serum PSA levels are not affected by the menstrual cycle or the menopause, but are increased in subjects with polycystic ovary syndrome.

Authors:  A Burelli; R Cionini; E Rinaldi; E Benelli; E Fiore; D Canale; W Bencivelli; C Nencetti; A Pinchera; E Pucci
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

Review 5.  Cellular signaling perturbation by natural products.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong
Journal:  Cell Signal       Date:  2009-03-16       Impact factor: 4.315

6.  Free/Total Serum Prostate-Specific Antigen Ratio in Women with Colorectal Cancer Has Prognostic Significance.

Authors:  Nüvit Duraker; Zeynep Civelek Çaynak; Didem Can Trabulus
Journal:  J Gastrointest Cancer       Date:  2017-03

Review 7.  Multi-targeted therapy of cancer by genistein.

Authors:  Sanjeev Banerjee; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

Review 8.  Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?

Authors:  Yiwei Li; Dejuan Kong; Aamir Ahmad; Bin Bao; Fazlul H Sarkar
Journal:  Antioxid Redox Signal       Date:  2013-03-14       Impact factor: 8.401

9.  Prostate-specific antigen is increased in female patients with Cushing's disease.

Authors:  L Manetti; I Lupi; F Bogazzi; G Pellegrini; A Precisi; L Grasso; C Nencetti; M Gasperi; E Martino
Journal:  J Endocrinol Invest       Date:  2002-10       Impact factor: 4.256

Review 10.  Soy isoflavones and prostate cancer: a review of molecular mechanisms.

Authors:  Abeer M Mahmoud; Wancai Yang; Maarten C Bosland
Journal:  J Steroid Biochem Mol Biol       Date:  2013-12-25       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.